Scarica l'app Stockscreener
364.98
0.01%
-0.03
Dopo l'orario di chiusura:
364.98
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché WST Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
West Pharmaceutical Services Inc Borsa (WST) Ultime notizie
West Pharmaceutical Services Inc. stock outperforms competitors despite losses on the day - MarketWatch
Drug Development Inputs & Services Stocks Q2 Highlights: West Pharmaceutical Services (NYSE:WST) - Yahoo Finance
There’s one pharma-linked stock most investors have never heard of. It’s on Josh Brown’s list - cnbc.com
West Pharmaceutical Services, I (WST) Stock Forecasts - Yahoo Finance
West Pharmaceutical Services stock reports 13.80 percent revenue growth - AD HOC NEWS
Smith+Nephew Launches EVOS PELVIC System to Advance Trauma Care - Zacks Investment Research
West Pharmaceutical Services stock attracts analyst coverage - AD HOC NEWS
West Pharmaceutical stock enters earnings watch with USD 382.00 target - AD HOC NEWS
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
What Comes Next for West Pharmaceutical Services (NYSE:WST)? - Kalkine Media
Top West Pharmaceutical Services (WST) Competitors 2026 - MarketBeat
West Pharmaceutical Services stock gains after target rises - AD HOC NEWS
West Pharmaceutical stock rises 1.30 percent ahead of the open - AD HOC NEWS
West Pharmaceutical stock rises 2.71 percent after analyst upgrade - AD HOC NEWS
West Pharmaceutical stock gains 2.57 percent before the bell - AD HOC NEWS
West Pharmaceutical stock gains as Morgan Stanley turns bullish - AD HOC NEWS
West Pharmaceutical Poised to See EPS Upside to Current 2027 Wall Street Estimates, Morgan Stanley Says - marketscreener.com
West Pharmaceutical Services stock holds near its yearly range - AD HOC NEWS
Morgan Stanley Upgrades West Pharmaceutical Services to Overweight From Equalweight, Adjusts PT to $400 From $365 - Yahoo Finance
West Pharmaceutical stock holds near 52-week high as valuation debate intensifies - AD HOC NEWS
West Pharmaceutical Services (WST) Stock Analysis: A Healthcare Powerhouse with 11.89% Potential Upside - DirectorsTalk Interviews
West Pharmaceutical stock heads into the open after a 1.3% drop - AD HOC NEWS
West Pharmaceutical Services stock holds near fair value as valuation debate intensifies - AD HOC NEWS
What Is Drawing Attention To West Pharmaceutical Services (WST)? - Yahoo Finance
West Pharmaceutical Services stock holds a Moderate Buy rating - AD HOC NEWS
West Pharmaceutical stock holds Moderate Buy rating as Annex 1 work shapes outlook - ad-hoc-news.de
West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors - MarketWatch
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now - Yahoo Finance
West Pharma to cut 98 jobs as SmartDose production winds down in Arizona - Plastics News
West Pharmaceutical stock slips after recent Fed-driven drop but Q2 2026 results stay strong - AD HOC NEWS
West Pharmaceutical stock heads into the open after a sharp drop - AD HOC NEWS
West Pharmaceutical stock gains after raised 2026 guidance and strong Q2 figures - AD HOC NEWS
West Pharmaceutical stock heads into the open after a 2.76% gain - AD HOC NEWS
Is West Pharmaceutical Services Stock Outperforming the Nasdaq? - Yahoo Finance
West Pharmaceutical (NYSE: WST) HR leader exercises options, then sells 7,524 shares - Stock Titan
West Pharmaceutical Services Inc (WST): GF Score of 95 Signals S - GuruFocus
Morgan Stanley Maintains West Pharmaceutical Services(WST.US) With Hold Rating, Maintains Target Price $365 - Moomoo
West Pharmaceutical stock heads into the open after a 1.8% gain - AD HOC NEWS
Earnings Call Transcripts - Investing.com
West Pharmaceutical Services (WST) Stock Analysis: Robust Growth and a Promising 17% Upside - DirectorsTalk Interviews
West Pharmaceutical stock gains after insider sale and strong Q2 figures - ad-hoc-news.de
West Pharmaceutical Services senior VP favorite sells $2.77m in stock - Investing.com
West Pharmaceutical stock heads into the open after a 0.7 percent dip - ad-hoc-news.de
West Pharmaceutical Services Sr. VP & Chief HR Officer Sold Shares Worth Over $2.7M - TradingView
West Pharmaceutical (NYSE: WST) HR chief sells stock outside a 10b5-1 plan - Stock Titan
West Pharmaceutical CEO Michel Lagarde Granted Stock Options and RSUs in September 2026 - Kalkine Media
WEST PHARMACEUTICAL SERVICES, INC. : UBS RAISES TARGET PRICE TO $415 FROM $340 - webull.com
West Pharmaceutical (NYSE: WST) awards CEO 37K options and 14.8K RSUs vesting through 2031 - Stock Titan
West Pharmaceutical (NYSE: WST) CEO discloses initial 7,850-share stake - Stock Titan
West Pharmaceutical Services at Wells Fargo conference: growth outlook lifts By Investing.com - Investing.com Nigeria
West Pharmaceutical Services at Wells Fargo conference: growth outlook lifts - Investing.com
West Pharmaceutical stock gains as UBS lifts price target to USD 415 - AD HOC NEWS
Is West Pharmaceutical Services (WST) Stock A Bargain Or Fully Priced? - webull.com
0.28%
1.92%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):